Search images on Google      Product Monograph

Active Ingredients:

• inotuzumab ozogamicin, 0.9 MG/VIAL

DIN: 02473909

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE DOSE VIAL

Schedule: Prescription

Company: PFIZER CANADA ULC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FB - (ATC, WHO)
• L01FB01 - INOTUZUMAB OZOGAMICIN (WHO)

 

External Links for Besponsa:

Search on Google

• Besponsa side effects
• Besponsa dosage
• inotuzumab ozogamicin side effects
• inotuzumab ozogamicin dosage